158 related articles for article (PubMed ID: 30634030)
1. A thermo-responsive and self-healing liposome-in-hydrogel system as an antitubercular drug carrier for localized bone tuberculosis therapy.
Liu P; Guo B; Wang S; Ding J; Zhou W
Int J Pharm; 2019 Mar; 558():101-109. PubMed ID: 30634030
[TBL] [Abstract][Full Text] [Related]
2. A bioactive implant in situ and long-term releases combined drugs for treatment of osteoarticular tuberculosis.
Zhou CX; Li L; Ma YG; Li BN; Li G; Zhou Z; Shi F; Weng J; Zhang C; Wang F; Cui X; Wang L; Wang H
Biomaterials; 2018 Sep; 176():50-59. PubMed ID: 29857274
[TBL] [Abstract][Full Text] [Related]
3. Dopamine-assisted fixation of drug-loaded polymeric multilayers to osteoarticular implants for tuberculosis therapy.
Li D; Li L; Ma Y; Zhuang Y; Li D; Shen H; Wang X; Yang F; Ma Y; Wu D
Biomater Sci; 2017 Mar; 5(4):730-740. PubMed ID: 28218329
[TBL] [Abstract][Full Text] [Related]
4. Isoniazid conjugated poly(lactide-co-glycolide): long-term controlled drug release and tissue regeneration for bone tuberculosis therapy.
Huang D; Li D; Wang T; Shen H; Zhao P; Liu B; You Y; Ma Y; Yang F; Wu D; Wang S
Biomaterials; 2015 Jun; 52():417-25. PubMed ID: 25818448
[TBL] [Abstract][Full Text] [Related]
5. Isoniazid loaded core shell nanoparticles derived from PLGA-PEG-PLGA tri-block copolymers: in vitro and in vivo drug release.
Gajendiran M; Gopi V; Elangovan V; Murali RV; Balasubramanian S
Colloids Surf B Biointerfaces; 2013 Apr; 104():107-15. PubMed ID: 23298594
[TBL] [Abstract][Full Text] [Related]
6. Encapsulation of Isoniazid-conjugated Phthalocyanine-In-Cyclodextrin-In-Liposomes Using Heating Method.
Nkanga CI; Krause RWM
Sci Rep; 2019 Aug; 9(1):11485. PubMed ID: 31391517
[TBL] [Abstract][Full Text] [Related]
7. Anti-tuberculosis drug combination for controlled oral delivery using 3D printed compartmental dosage forms: From drug product design to in vivo testing.
Genina N; Boetker JP; Colombo S; Harmankaya N; Rantanen J; Bohr A
J Control Release; 2017 Dec; 268():40-48. PubMed ID: 28993169
[TBL] [Abstract][Full Text] [Related]
8. Instant hydrogelation encapsulates drugs onto implants intraoperatively against osteoarticular tuberculosis.
Li Y; Li L; Sha X; Zhang K; Li G; Ma Y; Zhou J; Hao Y; Zhang Z; Cui X; Tang PF; Wang L; Wang H
J Mater Chem B; 2021 Oct; 9(38):8056-8066. PubMed ID: 34491255
[TBL] [Abstract][Full Text] [Related]
9. A mesoporous silicon/poly-(DL-lactic-co-glycolic) acid microsphere for long time anti-tuberculosis drug delivery.
Xu W; Wei X; Wei K; Cao X; Zhong S
Int J Pharm; 2014 Dec; 476(1-2):116-23. PubMed ID: 25271077
[TBL] [Abstract][Full Text] [Related]
10. Sustained release of intravitreal flurbiprofen from a novel drug-in-liposome-in-hydrogel formulation.
Pachis K; Blazaki S; Tzatzarakis M; Klepetsanis P; Naoumidi E; Tsilimbaris M; Antimisiaris SG
Eur J Pharm Sci; 2017 Nov; 109():324-333. PubMed ID: 28843864
[TBL] [Abstract][Full Text] [Related]
11. Prevention of corneal neovascularization by subconjunctival injection of avastin® loaded thermosensitive hydrogels in rabbit model.
Xu X; Yu J; Shi H; Zhang J; Li X
Int J Pharm; 2018 Dec; 552(1-2):164-170. PubMed ID: 30217769
[TBL] [Abstract][Full Text] [Related]
12. PEG-
Wang S; Wang Z; Xu C; Cui L; Meng G; Yang S; Wu J; Liu Z; Guo X
J Biomater Appl; 2021 Apr; 35(9):1085-1095. PubMed ID: 33611960
[TBL] [Abstract][Full Text] [Related]
13. Controlled release of simvastatin-loaded thermo-sensitive PLGA-PEG-PLGA hydrogel for bone tissue regeneration: in vitro and in vivo characteristics.
Yan Q; Xiao LQ; Tan L; Sun W; Wu T; Chen LW; Mei Y; Shi B
J Biomed Mater Res A; 2015 Nov; 103(11):3580-9. PubMed ID: 25969423
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics evaluation of a thermosensitive chitosan based hydrogel containing liposomal doxorubicin.
Ren S; Dai Y; Li C; Qiu Z; Wang X; Tian F; Zhou S; Liu Q; Xing H; Lu Y; Chen X; Li N
Eur J Pharm Sci; 2016 Sep; 92():137-45. PubMed ID: 27388491
[TBL] [Abstract][Full Text] [Related]
15. Polyethylene-glycolylated isoniazid conjugate for reduced toxicity and sustained release.
Kakkar D; Tiwari AK; Chuttani K; Kumar R; Mishra K; Singh H; Mishra AK
Ther Deliv; 2011 Feb; 2(2):205-12. PubMed ID: 22833946
[TBL] [Abstract][Full Text] [Related]
16. Cytarabine-AOT catanionic vesicle-loaded biodegradable thermosensitive hydrogel as an efficient cytarabine delivery system.
Liu J; Jiang Y; Cui Y; Xu C; Ji X; Luan Y
Int J Pharm; 2014 Oct; 473(1-2):560-71. PubMed ID: 25066076
[TBL] [Abstract][Full Text] [Related]
17. Radiolabeling and evaluation of alginate blend-isoniazid microspheres by 99mTc for the treatment of tuberculosis in rabbit model.
Samad A; Sultana Y; Khar RK; Aqil M; Kalam MA; Chuttani K; Mishra AK
J Drug Target; 2008 Jul; 16(6):509-15. PubMed ID: 18604664
[TBL] [Abstract][Full Text] [Related]
18. Sustained release of isoniazid from a single injectable dose of poly (DL-lactide-co-glycolide) microparticles as a therapeutic approach towards tuberculosis.
Dutt M; Khuller GK
Int J Antimicrob Agents; 2001 Feb; 17(2):115-22. PubMed ID: 11165115
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary Delivery of Anti-Tubercular Drugs Using Ligand Anchored pH Sensitive Liposomes for the Treatment of Pulmonary Tuberculosis.
Bhardwaj A; Grobler A; Rath G; Goyal AK; Jain AK; Mehta A
Curr Drug Deliv; 2016; 13(6):909-22. PubMed ID: 26718489
[TBL] [Abstract][Full Text] [Related]
20. Inhaled microparticles of antitubercular antibiotic for in vitro and in vivo alveolar macrophage targeting and activation of phagocytosis.
Parikh R; Dalwadi S; Aboti P; Patel L
J Antibiot (Tokyo); 2014 May; 67(5):387-94. PubMed ID: 24569669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
